ABBOTT LABORATORIES

(ABT)
  Report
Delayed Nyse  -  04:06 2022-06-24 pm EDT
109.45 USD   +3.05%
06/24BTIG Adjusts Abbott Laboratories' Price Target to $130 From $140, Reiterates Buy Rating
MT
06/23GLOBAL MARKETS LIVE : Uber, Tesla, BMW, Revlon, Alibaba...
06/22US to Reportedly Import Baby Formula From Mexico to Address Supply Shortage
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

US House Presses Baby Formula Makers on Steps Being Taken to Address Shortage

05/13/2022 | 03:15pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ABBOTT LABORATORIES 3.05% 109.45 Delayed Quote.-22.23%
NESTLÉ S.A. 2.91% 111.64 Delayed Quote.-12.40%
PERRIGO COMPANY PLC 2.23% 41.21 Delayed Quote.5.94%
All news about ABBOTT LABORATORIES
06/24BTIG Adjusts Abbott Laboratories' Price Target to $130 From $140, Reiterates Buy Rating
MT
06/23GLOBAL MARKETS LIVE : Uber, Tesla, BMW, Revlon, Alibaba...
06/22US to Reportedly Import Baby Formula From Mexico to Address Supply Shortage
MT
06/16Abbott, Allstate fall; Procter & Gamble, NexTier rise
AQ
06/16Global markets live: McDonald's, Tesla, Revlon, Credit Suisse, Ferrari...
06/16Baby formula crunch in U.S. forces scramble to boost supplies
RE
06/16WALL STREET STOCK EXCHANGE : A central bank bonanza
06/16Severe Storms Prompt Abbott Laboratories to Halt Production of Baby Formula in Michigan
MT
06/16MARKETSCREENER’S WORLD PRESS REVIEW : June 16, 2022
06/15Bubs Australia shares surge on infant formula supply deal with Walmart
RE
More news
Analyst Recommendations on ABBOTT LABORATORIES
More recommendations
Financials (USD)
Sales 2022 41 821 M - -
Net income 2022 6 669 M - -
Net Debt 2022 4 341 M - -
P/E ratio 2022 29,7x
Yield 2022 1,72%
Capitalization 192 B 192 B -
EV / Sales 2022 4,69x
EV / Sales 2023 4,63x
Nbr of Employees 113 000
Free-Float 87,5%
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 20
Last Close Price 109,45 $
Average target price 135,75 $
Spread / Average Target 24,0%
EPS Revisions
Managers and Directors
Robert B. Ford Chairman, President, Chief Executive Officer & COO
Robert Emmett Funck Chief Financial Officer & Executive VP-Finance
Sabina Ewing Chief Investment Officer, VP-Business & Technology
Glenn Fletcher Tilton Independent Director
William A. Osborn Lead Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ABBOTT LABORATORIES-22.23%191 641
MEDTRONIC PLC-12.79%119 876
BECTON, DICKINSON AND COMPANY2.10%71 528
BAXTER INTERNATIONAL INC.-22.20%33 626
HOYA CORPORATION-30.57%31 948
AMERISOURCEBERGEN CORPORATION8.81%31 097